e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Proteases and the matrix
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung remodeling in cigarette smoke-induced emphysema is independent of nitric oxide participation
S. Valença, C. Rueff-Barroso, W. Pimenta, R. Nesi, E. Trajano, M. Silva, A. Mello, L. C. Porto (Brazil)
Source:
Annual Congress 2010 - Proteases and the matrix
Session:
Proteases and the matrix
Session type:
Thematic Poster Session
Number:
4373
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Valença, C. Rueff-Barroso, W. Pimenta, R. Nesi, E. Trajano, M. Silva, A. Mello, L. C. Porto (Brazil). Lung remodeling in cigarette smoke-induced emphysema is independent of nitric oxide participation. Eur Respir J 2010; 36: Suppl. 54, 4373
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
iNOS-derived nitric oxide contributes to lung remodelling in an elastase-induced emphysema model
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Nitric oxide in the airways after smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 155s
Year: 2004
Acute effect of cigarette smoke on bronchial blood flow and exhaled nitric oxide
Source: Eur Respir J 2005; 26: Suppl. 49, 480s
Year: 2005
Nitric oxide modulates vascular remodelling in a model of chronic allergic lung inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 432s
Year: 2006
Lung allergic inflammation and stress: effects of capsaicin neonatal treatment on pulmonary mechanics and exhaled nitric oxide in stressed rats
Source: Eur Respir J 2002; 20: Suppl. 38, 105s
Year: 2002
Effect of tobacco smoke exposure on exhaled nitric oxide levels in Tunisian asthmatics
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Effect of cigarette smoke exposure on exhaled nitric oxide and its relation to asthma and hay feverin adult NHANES subjects
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Different relation between exhaled nitric oxide and lung function with regard to current smoking
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Exhaled nitric oxide as a marker of asthma control in smoking patients
Source: Eur Respir J 2009; 33: 1295-1301
Year: 2009
Characteristics of exercise induced bronchoconstriction in asthmatic children according to exhaled nitric oxide
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016
Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Exhaled nitric oxide in infants: a marker of inflammation?
Source: Eur Respir Monogr 2010; 49: 56-70
Year: 2010
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Chronic nitric oxide inhibition increases airway remodeling in guinea pigs with lung inflammation
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004
Alveolar nitric oxide is increased in uncontrolled asthma
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma
Source: Eur Respir J 2005; 25: 289-294
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept